![Lee Cooper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lee Cooper
Direktor/Vorstandsmitglied bei
Capstan Therapeutics, Inc.
Profil
Lee Cooper is the founder of Enlight Bio, Inc. (2018).
Current jobs include Director at Senti Sub I, Inc. (2020), Senior Director of Venture Investments at Leaps By Bayer (2020), Director at Capstan Therapeutics, Inc. (2022), and Scientific Advisor at FutuRx Ltd. Former jobs include Associate Director-Development & Corporate Finance at Moderna, Inc. (2015-2017), Director at Senti Biosciences, Inc., Entrepreneur in Residence at RA Capital Management LP (Private Equity) (2019), Consultant at Artisan Healthcare Consulting, Inc. (2009-2012), and Board Member at Triumvira Immunologics USA, Inc. Education includes undergraduate degree from Dartmouth College, graduate degree from Columbia Law School, and MBA from Columbia Business School.
Aktive Positionen von Lee Cooper
| Unternehmen | Position | Beginn |
|---|---|---|
Leaps By Bayer /US/
 Leaps By Bayer /US/ Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.01.2020 |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Direktor/Vorstandsmitglied | 01.01.2020 |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Direktor/Vorstandsmitglied | 01.06.2022 |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Berater | - |
Ehemalige bekannte Positionen von Lee Cooper
| Unternehmen | Position | Ende |
|---|---|---|
Enlight Bio, Inc. | Gründer | 31.12.2019 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Corporate Officer/Principal | 31.10.2019 |
| MODERNA, INC. | Corporate Officer/Principal | 31.12.2017 |
Artisan Healthcare Consulting, Inc.
 Artisan Healthcare Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic and analytic advice to healthcare product companies | Corporate Officer/Principal | 31.12.2012 |
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Direktor/Vorstandsmitglied | - |
Ausbildung von Lee Cooper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer | Commercial Services |
Leaps By Bayer /US/
Leaps By Bayer /US/ Investment ManagersFinance Functions as an alternative investment manager | Finance |
Enlight Bio, Inc. | |
Artisan Healthcare Consulting, Inc.
Artisan Healthcare Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic and analytic advice to healthcare product companies | Commercial Services |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
